Elanco Animal Health (ELAN) Construction in Progress (2024)
Elanco Animal Health's (ELAN) quarterly Construction in Progress came in at $42.0 million in Q4 2024.
Powered by 
Analysis
Elanco Animal Health (ELAN) Construction in Progress (2024) Analysis & Trends
Elanco Animal Health has disclosed Construction in Progress across 1 years of filings, most recently posting $42.0 million for Q4 2024.
- In Q4 2024, Construction in Progress changed N/A year-over-year to $42.0 million; the TTM figure through Dec 2024 stood at $42.0 million (changed N/A YoY), while the FY2024 annual figure was $42.0 million, changed N/A from the prior year.
- Construction in Progress came in at $42.0 million for Q4 2024 at Elanco Animal Health.
- In the past five years, Construction in Progress ranged from a high of $42.0 million in Q4 2024 to a low of $42.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.03 Bn | 39.83 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.51 Bn | 28.83 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.50 Bn | 10.97 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | - |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.81 Mn | 68.71 Mn | - | 86,005.49 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |